ELEVANCE HEALTH, INC. Increase (Decrease) in Deferred Revenue
ELEVANCE HEALTH, INC. (ELV) reported Increase (Decrease) in Deferred Revenue of $147.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-07-15
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$119.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $266.00M, a 101.52% increase year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$338.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $270.00M, a 13.46% decline year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2025 was -$15.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2024 was -$113.00M, a 138.97% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2023 was $290.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in deferred revenue for fiscal 2022 was -$42.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$119.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $147.00M 10-Q · filed 2026-07-15 | -$191.00M derived: sum of 3 quarters · filed 2026-07-15 | $79.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-03-31 | $266.00M 10-Q · filed 2026-04-22 | -$72.00M derived: sum of 2 quarters · filed 2026-04-22 | $198.00M derived: sum of 3 quarters · filed 2026-04-22 | $119.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-12-31 | -$338.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$68.00M derived: sum of 2 quarters · filed 2026-02-06 | -$147.00M derived: sum of 3 quarters · filed 2026-07-15 | -$15.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | $270.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $191.00M derived: sum of 2 quarters · filed 2026-07-15 | $323.00M 10-Q · filed 2025-10-21 | -$182.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-06-30 | -$79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $53.00M 10-Q · filed 2026-07-15 | -$452.00M derived: sum of 3 quarters · filed 2026-07-15 | -$140.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-03-31 | $132.00M 10-Q · filed 2026-04-22 | -$373.00M derived: sum of 2 quarters · filed 2026-04-22 | -$61.00M derived: sum of 3 quarters · filed 2026-04-22 | -$53.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | -$505.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$193.00M derived: sum of 2 quarters · filed 2026-02-06 | -$185.00M derived: sum of 3 quarters · filed 2026-02-06 | -$113.00M 10-K · filed 2026-02-06 |
| 2024-09-30 | $312.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $320.00M derived: sum of 2 quarters · filed 2025-10-21 | $392.00M 10-Q · filed 2025-10-21 | -$2.54B derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-17 | $80.00M 10-Q · filed 2025-07-17 | -$2.85B derived: sum of 3 quarters · filed 2026-02-06 | -$2.98B derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $72.00M 10-Q · filed 2025-04-22 | -$2.86B derived: sum of 2 quarters · filed 2026-02-06 | -$2.98B derived: sum of 3 quarters · filed 2026-02-06 | -$2.92B derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | -$2.93B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$3.06B derived: sum of 2 quarters · filed 2026-02-06 | -$2.99B derived: sum of 3 quarters · filed 2026-02-06 | $290.00M 10-K · filed 2026-02-06 |
| 2023-09-30 | -$126.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-17 | -$62.00M derived: sum of 2 quarters · filed 2024-10-17 | $3.22B 10-Q · filed 2024-10-17 | $630.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-17 | $3.35B 10-Q · filed 2024-07-17 | $756.00M derived: sum of 3 quarters · filed 2025-02-20 | $3.49B derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $3.28B 10-Q · filed 2024-04-18 | $692.00M derived: sum of 2 quarters · filed 2025-02-20 | $3.42B derived: sum of 3 quarters · filed 2025-02-20 | $3.18B derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$2.59B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $140.00M derived: sum of 2 quarters · filed 2025-02-20 | -$99.00M derived: sum of 3 quarters · filed 2025-02-20 | -$42.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $2.73B derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-10-18 | $2.49B derived: sum of 2 quarters · filed 2023-10-18 | $2.55B 10-Q · filed 2023-10-18 | $2.74B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$239.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-09-29 | -$182.00M 10-Q/A · filed 2023-09-29 | $13.00M derived: sum of 3 quarters · filed 2024-02-21 | -$115.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $57.00M 10-Q · filed 2023-04-19 | $252.00M derived: sum of 2 quarters · filed 2024-02-21 | $124.00M derived: sum of 3 quarters · filed 2024-02-21 | $63.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $195.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $67.00M derived: sum of 2 quarters · filed 2024-02-21 | $6.00M derived: sum of 3 quarters · filed 2024-02-21 | -$113.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$128.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-19 | -$189.00M derived: sum of 2 quarters · filed 2022-10-19 | -$308.00M 10-Q · filed 2022-10-19 | -$11.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-06-30 | -$61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$180.00M 10-Q · filed 2022-07-20 | $117.00M derived: sum of 3 quarters · filed 2023-10-18 | $132.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-03-31 | -$119.00M 10-Q · filed 2022-04-20 | $178.00M derived: sum of 2 quarters · filed 2023-10-18 | $193.00M derived: sum of 3 quarters · filed 2023-10-18 | $192.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2020-12-31 | $297.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $312.00M derived: sum of 2 quarters · filed 2023-10-18 | $311.00M derived: sum of 3 quarters · filed 2023-10-18 | $202.00M 10-Q · filed 2023-10-18 |
| 2020-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $14.00M derived: sum of 2 quarters · filed 2021-10-20 | -$95.00M 10-Q · filed 2021-10-20 | -$26.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | -$110.00M 10-Q · filed 2021-07-21 | -$41.00M derived: sum of 3 quarters · filed 2022-02-16 | $7.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$109.00M 10-Q · filed 2021-04-21 | -$40.00M derived: sum of 2 quarters · filed 2022-02-16 | $8.00M derived: sum of 3 quarters · filed 2022-02-16 | -$90.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $117.00M derived: sum of 2 quarters · filed 2022-02-16 | $19.00M derived: sum of 3 quarters · filed 2022-02-16 | $115.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$50.00M derived: sum of 2 quarters · filed 2020-10-28 | $46.00M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | -$98.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$2.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $96.00M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | -$36.00M 10-K · filed 2021-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |